Search
forResearch 3 of 49
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- Phase I Clinical Testing Antimalarial Drugs.
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →